Gland Pharma Shareholding Pattern
- Market cap
- ₹52,000 crore
- P/E
- 46.1
- P/B
- 5.02
- ROE
- 10.5%
- Dividend yield
- 0.63%
As of 30-JUN-2026, promoters held 51.77% of Gland Pharma (-0.06 pp from 31-MAR-2026), foreign institutional investors 8.74%, domestic institutions 30.44% and the public 9.05%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Gland Pharma shareholding pattern — frequently asked questions
What is the promoter holding in Gland Pharma?
Promoters held 51.77% of Gland Pharma as of 30-JUN-2026, down 0.06 pp from 51.83% in 31-MAR-2026.
How much do FIIs hold in Gland Pharma?
Foreign institutional investors held 8.74% of Gland Pharma as of 30-JUN-2026, a change of +1.44 pp from the previous quarter.
How much do domestic institutions hold in Gland Pharma?
Domestic institutional investors, including mutual funds and insurers, held 30.44% of Gland Pharma as of 30-JUN-2026 (-2.91 pp from the previous quarter).
Who owns Gland Pharma?
As of 30-JUN-2026, Gland Pharma's shareholders were promoters (51.77%), foreign institutional investors 8.74%, domestic institutions 30.44% and the public 9.05%, as filed with the stock exchanges.
Same Data For Peers
Trade Gland Pharma With ATS
Track GLAND live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.